Responsible for marketing & promotions of Carrier Splits

Responsible for sales & marketing objectives of the Bone & Joint franchise including ARCOXIA ( NSAID market), Fosavance ( Osteoporosis) & Diprospan ( adrenal corticosteroid). LCM & Business Development Initiatives for the franchise

Allergy, Asthma, Topical corticosteroids & Finasteride

Launch MS & ADHD franchise

PRIMARY OBJECTIVE :Ensure the achievement of sales, market share, and management result objectives of key ophthalmic brand Lucentis , Visudyne and an OTC brand Vitalux Plus KEY RESULT AREAS AND RESPONSIBILITIES :Lead and support a team of specialist representatives promoting the key ophthalmic brand Lucentis (2 specialists)Develop core competencies of the specialist representatives through effective coaching Assist and monitor the team in building strong… Show more PRIMARY OBJECTIVE :Ensure the achievement of sales, market share, and management result objectives of key ophthalmic brand Lucentis , Visudyne and an OTC brand Vitalux Plus KEY RESULT AREAS AND RESPONSIBILITIES :Lead and support a team of specialist representatives promoting the key ophthalmic brand Lucentis (2 specialists)Develop core competencies of the specialist representatives through effective coaching Assist and monitor the team in building strong customer baseEnsure effective implementation of performance frontier selling skills Ensure the achievement of sales, market share, and management result objectives of products or portfolio franchise through the development and effective implementation of marketing plans and promotional strategies ACHIEVEMENTS : Successful presentation of a business case which will reduce the price of brand Lucentis. Price reduction will address key issue of limited access to drug due premium price versus competitionClosed a contract with a key account which will provide Php20 mio in sales constituting 51% to total brand sales in 2010Conceptualization of a pricing scheme that will make treatments more accessible to more patients : 'Hope for Sight Expanded Program' Show less

Exceeded sales targets of all managed brands in 2008 from different therapeutic classes Helped design " Kaagapay" program which aimed to address price issues and genericization of the various markets where Novartis brands are presentLaunched Stalev reaching no. 3 position in three (3) years after launch; KEY RESULT AREAS AND RESPONSIBILITIES : A. Managed brands Alphagan , Alphagan P, Lumigan and Cellufresh artificial tears ACHIEVEMENTS:… Show more Exceeded sales targets of all managed brands in 2008 from different therapeutic classes Helped design " Kaagapay" program which aimed to address price issues and genericization of the various markets where Novartis brands are presentLaunched Stalev reaching no. 3 position in three (3) years after launch; KEY RESULT AREAS AND RESPONSIBILITIES : A. Managed brands Alphagan , Alphagan P, Lumigan and Cellufresh artificial tears ACHIEVEMENTS: 1) Therapeutic class leadership for anti-glaucoma brands 2) Introduced the first preservative free artificial tear brand in the market : Cellufresh Show less

KEY RESULT AREAS AND RESPONSIBILITIES : Managed neuroleptic brands Nozinan ( levomepromazine ), Laractyl ( chlorpromazine ) Launched tricyclic antidepressant Surmontil